BA
The Boeing Company
BA offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CR
Crane Company
CR has the edge over BA overall, supported by stronger modeled upside and lower modeled downside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Healthy |
CR's revenue, profitability, cash flow and balance sheet are all currently healthy.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CR in the historical PE scenario, which offers more potential upside but is not a forecast.
CR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 27x | $209 | — |
| Cheap | 29x | $167 | -20% |
| Fair | 31x | $180 | -14% |
| Expensive | 34x | $198 | -5.7% |
| Current | 36x | $209 | — |
Historical ranges are pointers, not guarantees.
CR's PE is in its expensive range at 36x. If earnings grow as analysts expect, today's price would be 27x next year's earnings, in its cheap range.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
CR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CR, with profitability improving.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
CR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.81 | +34% |
| Q3 2026 | $5.83 | -6.6% |
| Q2 2026 | $5.73 | -4.7% |
| Q1 2026 | $5.57 | -3.5% |
| Q4 2025 | $6.26 | +24% |
| Q3 2025 | $6.24 | +18% |
| Q2 2025 | $6.01 | +22% |
| Q1 2025 | $5.77 | +29% |
| Q4 2024 | $5.06 | +14% |
CR has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over CR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $754.6M | +28% |
| Q2 2026 | $724.7M | +26% |
| Q1 2026 | $696.4M | +25% |
| Q4 2025 | $581M | +6.8% |
| Q3 2025 | $589.2M | -1.3% |
| Q2 2025 | $577.2M | -0.7% |
| Q1 2025 | $557.6M | -1.4% |
| Q4 2024 | $544.1M | +2.1% |
CR's revenue is recovering but still below its 2021 peak: $755M last quarter, up 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | -1.5 points |
| Q2 2026 | 20% | +2.1 points |
| Q1 2026 | 14% | -3.8 points |
| Q4 2025 | 18% | +1.7 points |
| Q3 2025 | 20% | +2.5 points |
| Q2 2025 | 18% | +1.2 points |
| Q1 2025 | 18% | +2.3 points |
| Q4 2024 | 16% | +3.3 points |
CR has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA's free cash flow has turned positive after six years mostly in the red: $16M over the past year.
CR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $116.3M | -0.4% |
| Q2 2026 | $107.7M | +21% |
| Q1 2026 | -$40.2M | +$20.2M |
| Q4 2025 | $196M | +7.2% |
| Q3 2025 | $116.8M | +61% |
| Q2 2025 | $88.9M | +63% |
| Q1 2025 | -$60.4M | +$28.6M |
| Q4 2024 | $182.9M | +25% |
CR generated $380M in free cash flow over the past year, up 16% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +100K shares |
| 1 year | +0.3% | +200K shares |
| 3 years | +2.3% | +1.3M shares |
| 5 years | -1.2% | -700K shares |
| Available history | -1.2% | -700K shares |
CR has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $27.9M |
| Q1 2022 | $175.8M |
| Q4 2021 | $96.3M |
| Q3 2021 | — |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.1x | Net Cash |
CR has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.1 | Neutral |
| Stochastic | 47.0 | Neutral |
CR's weekly RSI is 54 (neutral) and its Stochastic is 47 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over CR on valuation relative to its sector.
CR PE vs Industrials Sector
| Metric | CR | Sector median | Relative |
|---|---|---|---|
| PE | 36x | 24x | 50% above |
| PE % | 91 | 59 | 32 pts above |
CR is trading at 36x earnings, a 50% premium to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
CR has stronger trend alignment. BA is above 0 of 5 weekly averages versus CR above 4 of 4.
CR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $202.1 | 3.6% above |
| 20 week MA | $208.4 | 0.5% above |
| 50 week MA | $197.0 | 6.3% above |
| 100 week MA | $184.9 | 13% above |
CR is in an uptrend: it's above all four of its weekly moving averages, and 13% above its 100-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $105.7 | $118.1 | +12% |
| 2024 | $118.1 | $153.9 | +30% |
| 2025 | $153.9 | $187.8 | +22% |
| 2026 YTD | $187.8 | $209.5 | +12% |
CR has the edge over BA on returns for 2026, with the stronger performance.